LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer

Triple negative breast cancer (TNBC) is an aggressive type of breast cancer with high heterogeneity. To date, there is no efficient therapy for TNBC patients and the prognosis is poor. It is urgent to find new biomarkers for the diagnosis of TNBC or efficient therapy targets. As an area of focus in...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncotarget
Asıl Yazarlar: Lv, Mingming, Xu, Pengfei, Wu, Ying, Huang, Lei, Li, Wenqu, Lv, Shanshan, Wu, Xiaowei, Zeng, Xin, Shen, Rong, Jia, Xuemei, Yin, Yongmei, Gu, Yun, Yuan, Hongyan, Xie, Hui, Fu, Ziyi
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Impact Journals LLC 2016
Konular:
Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4914340/
https://ncbi.nlm.nih.gov/pubmed/26910840
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.7509
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller